학술논문
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer
Document Type
Article
Author
Desroys du Roure, P.; Mallavialle, A.; Alcaraz, L.B.; Mansouri, H.; Fenou, L.; Garambois, V.; Rubio, L.; David, T.; Ngo, G.; Martineau, P.; Laurent-Matha, V.; Roger, P.; Guiu, S.; Chardès, T.; Gros, L.; Liaudet-Coopman, E.; Lajoie, L.; Coenon, L.; Villalba, M.; Boissière-Michot, F.; Chateau, M.-C.; Jarlier, M.
Source
In: Journal for immunotherapy of cancer . (Journal for immunotherapy of cancer, 30 January 2024, 12(1))
Subject
Language
English
ISSN
20511426